Mala Murthy - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
29 Nov 2024
Net transactions value
-$104,755
Form type
4
Filing time
03 Dec 2024, 17:28:10 UTC
Previous filing
04 Sep 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2,641 +3.1% 88,408 29 Nov 2024 Direct F1
transaction TDOC Common Stock Options Exercise +3,369 +3.8% 91,777 29 Nov 2024 Direct F2
transaction TDOC Common Stock Options Exercise +2,044 +2.2% 93,821 29 Nov 2024 Direct F2
transaction TDOC Common Stock Options Exercise +7,750 +8.3% 101,571 29 Nov 2024 Direct F2
transaction TDOC Common Stock Sale $104,755 -8,783 -8.6% $11.93 92,788 02 Dec 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -2,641 -17% $0.000000 13,208 29 Nov 2024 Common Stock 2,641 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -3,369 -50% $0.000000 3,369 29 Nov 2024 Common Stock 3,369 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -2,044 -33% $0.000000 4,088 29 Nov 2024 Common Stock 2,044 Direct F2, F6
transaction TDOC Restricted Stock Units Options Exercise $0 -7,750 -17% $0.000000 38,754 29 Nov 2024 Common Stock 7,750 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.